Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 1026
Gene Symbol: CDKN1A
CDKN1A
0.020 Biomarker disease BEFREE Cyclin-dependent kinase-inhibitor 1 (CDKN1A) in the squamous epithelium of the oropharynx: possible implications of molecular biology and compartmentation. 11299759 2001
Entrez Id: 7157
Gene Symbol: TP53
TP53
0.040 AlteredExpression disease BEFREE TP53 inactivation is a major mechanism of HPV-related carcinogenesis in the oral cavity and oropharynx. 14744758 2004
Entrez Id: 7442
Gene Symbol: TRPV1
TRPV1
0.010 AlteredExpression disease BEFREE TRPV1 and TRPA1 are widely expressed in the human oropharynx with two distinct patterns. 26530852 2016
Entrez Id: 23583
Gene Symbol: SMUG1
SMUG1
0.010 Biomarker disease BEFREE FDG PET/CT demonstrated diffuse tumor-like mucosal/submucosal lesions with intense uptake involving the oropharynx, supraglottis, and hypopharynx. 28134697 2017
Entrez Id: 3702
Gene Symbol: ITK
ITK
0.010 Biomarker disease BEFREE ITK-SNAP software was employed for delimitation of the oropharynx. 28735346 2017
Entrez Id: 2059
Gene Symbol: EPS8
EPS8
0.010 AlteredExpression disease BEFREE Eps8 expression was detected in 49% of combined OCSCC and OPSCC cases. 29107665 2018
Entrez Id: 79054
Gene Symbol: TRPM8
TRPM8
0.010 AlteredExpression disease BEFREE TRPM8 agonists and acidic solutions can improve the swallow response in patients with OD, but little is known about the expression of TRPM8, ASIC1, and ASIC3 in the human oropharynx. 29971861 2018
Entrez Id: 842
Gene Symbol: CASP9
CASP9
0.010 Biomarker disease BEFREE CASP9 c.-1339AG or GG plus CASP3 c.-1191AG or GG genotypes were associated with oral cavity or oropharynx SCC early onset. 30903678 2019
Entrez Id: 4041
Gene Symbol: LRP5
LRP5
0.010 GeneticVariation disease BEFREE A 59-year-old woman carrying a novel LRP5 missense mutation, Arg154Met, manifested skeletal disease affecting her oropharynx as well as dense bones, showing that exuberant LRP5 effects are not always benign. 15824861 2005
Entrez Id: 2064
Gene Symbol: ERBB2
ERBB2
0.010 Biomarker disease BEFREE A retrospective chart review was performed of a patient who presented with a TNM classification III HNSCC of the oropharynx, positive for human papillomavirus (HPV) who had a complete response to a human epidermal growth factor receptor 2 (HER2)-targeted therapy. 27653501 2017
Entrez Id: 115482713
Gene Symbol: H3P10
H3P10
0.100 Biomarker disease BEFREE Age, smoking, N3 disease, T4 disease, and a negative p16 status were associated with the development of distant metastases in patients with squamous cell cancers of the oropharynx treated definitively with concurrent chemoradiation. 30548235 2019
Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
0.100 Biomarker disease BEFREE Age, smoking, N3 disease, T4 disease, and a negative p16 status were associated with the development of distant metastases in patients with squamous cell cancers of the oropharynx treated definitively with concurrent chemoradiation. 30548235 2019
Entrez Id: 115482713
Gene Symbol: H3P10
H3P10
0.100 Biomarker disease BEFREE Among those HNSCCs that were positive for HR-HPV, 18 (100%) of 18 originated from the oropharynx, whereas only two (13%) of 15 HR-HPV-negative HNSCCs originated from the oropharynx (χ(2) test, P < .05). p16 immunohistochemical assay and HPV 16 in situ hybridization on corresponding histologic specimens were concordant with cytologic HR-HPV results. 25873503 2015
Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
0.100 Biomarker disease BEFREE Among those HNSCCs that were positive for HR-HPV, 18 (100%) of 18 originated from the oropharynx, whereas only two (13%) of 15 HR-HPV-negative HNSCCs originated from the oropharynx (χ(2) test, P < .05). p16 immunohistochemical assay and HPV 16 in situ hybridization on corresponding histologic specimens were concordant with cytologic HR-HPV results. 25873503 2015
Entrez Id: 4351
Gene Symbol: MPI
MPI
0.010 AlteredExpression disease BEFREE An in vivo model for P. aeruginosa colonization in the upper airways revealed an increased bacterial burden in the trachea and oropharynx of nontherapeutic CF mice compared with mice treated either with an intratracheal delivery adeno-associated viral vector 5 expressing murine MPI, or a hypermannose water diet. 20693405 2011
Entrez Id: 7157
Gene Symbol: TP53
TP53
0.040 GeneticVariation disease BEFREE Apoptosis was not observed in tumors carrying the arginine allele. p53 mutations were detected in 29.6% of SCCHN and preferentially occurred at the arginine allele (P = 0.01). p53 alterations were more frequently observed in tumors of the oral cavity, oropharynx and hypopharynx, whereas they were rare in larynx carcinomas (P = 0.07). 15039212 2004
Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
0.100 Biomarker disease BEFREE As illustrated in this case, immunohistochemistry of the FNAC specimen for p16 was successful in determining the thyroid tumor as a metastatic lesion from the oropharynx. 29445071 2018
Entrez Id: 115482713
Gene Symbol: H3P10
H3P10
0.100 Biomarker disease BEFREE As illustrated in this case, immunohistochemistry of the FNAC specimen for p16 was successful in determining the thyroid tumor as a metastatic lesion from the oropharynx. 29445071 2018
Entrez Id: 6387
Gene Symbol: CXCL12
CXCL12
0.010 AlteredExpression disease BEFREE Biopsies from 141 HNSCC tumours of the oral cavity, oropharynx and hypopharynx were evaluated for SDF-1 and CXCR4 expression by immunofluorescence. 29061496 2018
Entrez Id: 7852
Gene Symbol: CXCR4
CXCR4
0.010 AlteredExpression disease BEFREE Biopsies from 141 HNSCC tumours of the oral cavity, oropharynx and hypopharynx were evaluated for SDF-1 and CXCR4 expression by immunofluorescence. 29061496 2018
Entrez Id: 55107
Gene Symbol: ANO1
ANO1
0.010 Biomarker disease BEFREE By contrast, OPSCCs had significantly fewer CCND1 (23.1%) and ANO1 (17.3%) gains, and significantly more PIK3CA (26.9%) gains. 27750372 2017
Entrez Id: 5290
Gene Symbol: PIK3CA
PIK3CA
0.010 Biomarker disease BEFREE By contrast, OPSCCs had significantly fewer CCND1 (23.1%) and ANO1 (17.3%) gains, and significantly more PIK3CA (26.9%) gains. 27750372 2017
Entrez Id: 836
Gene Symbol: CASP3
CASP3
0.010 GeneticVariation disease BEFREE CASP9 c.-1339AG or GG plus CASP3 c.-1191AG or GG genotypes were associated with oral cavity or oropharynx SCC early onset. 30903678 2019
Entrez Id: 5891
Gene Symbol: MOK
MOK
0.010 Biomarker disease BEFREE Differences in the locations of HNSCCs were reflected by different RAGE family members being expressed most frequently: larynx, RAGE-1; oropharynx, RAGE-2; and hypopharynx, RAGE-4. 12206267 2002
Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
0.100 AlteredExpression disease BEFREE Different studies revealed that: (i) 15-25% of head and neck squamous cell carcinomas (HNSCCs) are clonally associated with high risk HPV types (type 16); (ii) the oropharynx and particularly the tonsils are the most susceptible sites; (iii) patients with HPV-positive tumours present with more advanced stages of disease, are relatively younger, do not have extravagant tobacco and alcohol intake and seem to have a better survival; (iv) HPV-positive tumours are characterized by poor differentiation grade and a basaloid appearance; and (v) HPV-positive tumours exhibit integrated HPV DNA, wild-type p53, pRb downregulation and overexpression of p16INK4A. 15224887 2004